Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q34462134)
Watch
English
Caelyx: phase II studies in ovarian cancer
scientific article
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed ID
11741768
retrieved
2 August 2017
review article
1 reference
stated in
Europe PubMed Central
title
Caelyx: phase II studies in ovarian cancer
(English)
1 reference
stated in
Europe PubMed Central
PubMed ID
11741768
retrieved
2 August 2017
main subject
ovarian cancer
1 reference
based on heuristic
inferred from title
author name string
Johnston SR
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
11741768
retrieved
2 August 2017
Gore ME
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
11741768
retrieved
2 August 2017
publication date
1 December 2001
1 reference
stated in
Europe PubMed Central
PubMed ID
11741768
retrieved
2 August 2017
published in
European Journal of Cancer
1 reference
stated in
Europe PubMed Central
PubMed ID
11741768
retrieved
2 August 2017
volume
37 Suppl 9
1 reference
stated in
Europe PubMed Central
PubMed ID
11741768
retrieved
2 August 2017
page(s)
S8-14
1 reference
stated in
Europe PubMed Central
PubMed ID
11741768
retrieved
2 August 2017
cites work
Cancer statistics, 1999.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900329-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Carboplatin reinduction after taxane in patients with platinum-refractory epithelial ovarian cancer.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900329-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Taxol: a unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900329-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase II trial of oral altretamine for relapsed ovarian carcinoma: evaluation of defining response by serum CA125
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900329-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Topotecan for the treatment of advanced epithelial ovarian cancer: an open-label phase II study in patients treated after prior chemotherapy that contained cisplatin or carboplatin and paclitaxel
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900329-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900329-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prolonged oral etoposide as second-line therapy for platinum-resistant and platinum-sensitive ovarian carcinoma: a Gynecologic Oncology Group study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900329-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Activity of Gemcitabine in Patients with Advanced Ovarian Cancer: Responses Seen Following Platinum and Paclitaxel
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900329-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The role of anthracyclines in epithelial ovarian cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900329-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Impact of doxorubicin on survival in advanced ovarian cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900329-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cyclophosphamide plus cisplatin versus cyclophosphamide, doxorubicin, and cisplatin chemotherapy of ovarian carcinoma: a meta-analysis. The Ovarian Cancer Meta-Analysis Project
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900329-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A phase I clinical trial and pharmacokinetic evaluation of liposome-encapsulated doxorubicin
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900329-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prolongation of the circulation time of doxorubicin encapsulated in liposomes containing a polyethylene glycol-derivatized phospholipid: pharmacokinetic studies in rodents and dogs
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900329-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900329-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Doxorubicin encapsulated in sterically stabilized liposomes for the treatment of a brain tumor model: biodistribution and therapeutic efficacy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900329-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Salvage chemotherapy for epithelial ovarian carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900329-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Liposomal doxorubicin: antitumor activity and unique toxicities during two complementary phase I studies.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900329-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase II study of liposomal doxorubicin in refractory ovarian cancer: antitumor activity and toxicity modification by liposomal encapsulation.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900329-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase II study of liposomal doxorubicin in platinum- and paclitaxel-refractory epithelial ovarian cancer.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900329-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Topotecan versus paclitaxel for the treatment of recurrent epithelial ovarian cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900329-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S0959-8049(01)00329-X
1 reference
stated in
Europe PubMed Central
PubMed ID
11741768
retrieved
2 August 2017
PubMed ID
11741768
1 reference
stated in
Europe PubMed Central
PubMed ID
11741768
retrieved
2 August 2017
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
